| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2012 | Catenarin prevents type 1 diabetes in non-obese diabetic mice via inhibition of leukocyte migration involving the MEK6/p38 and MEK7/JNK pathways | Shen, M. Y.; Lin, Y. P.; Yang, B. C.; Jang, Y. S.; Chiang, C. K.; Mettling, C.; Chen, Z. W.; Sheu, J. R.; Chang, C. T. L.; Lin, Y. L.; Yang, W. C. | Evidence-Based Complementary and Alternative Medicine 982396 | |||
| 2012 | Catenarin, an anthraquinone compound, inhibits CXCR4 and CCR5 pathways to protect against type 1 diabetes in NOD mice. A-174, 12th International Conference on the Immunology of Diabetes | Yang, W. C.; Shen, M. Y.; Jang, Y. S.; Chen, Z. W.; Chang, C. L. T. | ||||
| 2012 | Myeloid-derived suppressor cells reverse type 1 diabetes in NOD mice | Yang, W. C.; Shen, M. Y.; Jang, Y. S.; Chen, Z. W.; Chang, C. L. T. |
